Literature DB >> 1934236

Case-control evaluation of a school-age BCG vaccination programme in subtropical Australia.

A Patel1, F Schofield, V Siskind, E Abrahams, J Parker.   

Abstract

In 1956 a programme was initiated to vaccinate all children aged 12-14 years who were attending schools in Queensland, Australia. In view of the declining incidence of tuberculosis in Australia as a whole, there was a need to evaluate the effectiveness of the programme and its procedures. We therefore carried out a case-control study of Queensland's population, excluding certain known high-risk groups. Cases were Queensland residents with notified tuberculosis and of the appropriate age; two controls per case were chosen from the electoral roll. Information on vaccination status was obtained mainly from questionnaires and school records, where available. The results show that at best BCG vaccination had a modest protective effect, approximately 30% when the patients were diagnosed, which was on average 15 years after they had been vaccinated in the school programme. In the north the climate of Queensland is tropical, while in the more heavily populated south it is subtropical. A substantial proportion of the school records reported weak positive reactions to preliminary tuberculin testing, believed to be due largely to atypical mycobacteria. A similar phenomenon has been observed in other tropical regions, and may help to explain the apparent absence of a strongly protective effect for BCG vaccination.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934236      PMCID: PMC2393242     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  Tuberculin hypersensitivity following BCG vaccination in Brisbane school children.

Authors:  E W Abrahams
Journal:  Tubercle       Date:  1979-06

2.  Epidemiological evidence of the presence of non-tuberculous sensitivity to tuberculin in Queensland.

Authors:  E W ABRAHAMS; H SILVERSTONE
Journal:  Tubercle       Date:  1961-12

3.  Childhood tuberculosis in Queensland.

Authors:  F ARDEN
Journal:  Med J Aust       Date:  1950-09-30       Impact factor: 7.738

4.  The effects of misclassification on the estimation of relative risk.

Authors:  B A Barron
Journal:  Biometrics       Date:  1977-06       Impact factor: 2.571

5.  Confidence intervals for the odds ratio in case-control studies: the state of the art.

Authors:  J L Fleiss
Journal:  J Chronic Dis       Date:  1979

6.  Childhood tuberculosis. An epidemiological study.

Authors:  R Drummond
Journal:  Med J Aust       Date:  1969-11-22       Impact factor: 7.738

7.  'Original mycobacterial sin'.

Authors:  E W Abrahams
Journal:  Tubercle       Date:  1970-09

8.  Does infection with environmental mycobacteria suppress the protective response to subsequent vaccination with BCG?

Authors:  D Smith; P Reeser; S Musa
Journal:  Tubercle       Date:  1985-03

9.  Efficacy and applicability of mass B. C.G. vaccination in tuberculosis control.

Authors:  P D Hart
Journal:  Br Med J       Date:  1967-03-11

10.  The effects of the scheme for BCG vaccination of schoolchildren in England and Wales and the consequences of discontinuing the scheme at various dates.

Authors:  I Sutherland; V H Springett
Journal:  J Epidemiol Community Health       Date:  1989-03       Impact factor: 3.710

  10 in total
  2 in total

Review 1.  The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link?

Authors:  F Abebe; G Bjune
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

2.  Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children.

Authors:  Joaquim C V D Van-Dunem; Laura C Rodrigues; Luiz Claudio Arraes Alencar; Maria de Fátima Pessoa Militão-Albuquerque; Ricardo Arraes de Alencar Ximenes
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.